Shanghai Rendu Biotechnology Co., Ltd. Class ASSE: 688193

Announcement on Reply to the Regulatory Inquiry Letter Regarding Information Disclosure of the 2024 Annual Report

· Issued by Shanghai Rendu Biotechnology Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Reply to the Regulatory Inquiry Letter Regarding Information Disclosure of the 2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis